LSD1 Antibody, Unconjugated, Rabbit, Polyclonal

Artikelnummer: PRS-3761
Artikelname: LSD1 Antibody, Unconjugated, Rabbit, Polyclonal
Artikelnummer: PRS-3761
Hersteller Artikelnummer: 3761
Alternativnummer: PRS-3761-0.02,PRS-3761-0.1
Hersteller: ProSci
Wirt: Rabbit
Kategorie: Antikörper
Applikation: ELISA, IF, IHC-P, WB
Spezies Reaktivität: Human, Mouse, Rat
Immunogen: Anti-LSD1 antibody (3761) was raised against a peptide corresponding to 17 amino acids near the amino terminus of human LSD1. The immunogen is located within amino acids 40-90 of LSD1.
Konjugation: Unconjugated
Alternative Synonym: LSD1 Antibody: AOF2, KDM1, LSD1, BHC110, AOF2, KIAA0601, Lysine-specific histone demethylase 1A, BRAF35-HDAC complex protein BHC110
Klonalität: Polyclonal
Konzentration: 1 mg/mL
Molekulargewicht: Predicted: 93kDObserved: 110 kD
NCBI: 23028
UniProt: O60341
Puffer: LSD1 Antibody is supplied in PBS containing 0.02% sodium azide.
Formulierung: Liquid
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.
Anwendungsbeschreibung: WB: 0.2 - 2 µg/mL, IHC-P: 2 µg/mL, IF: 20 µg/mL.Antibody validated: Western Blot in human, mouse and rat samples, Immunohistochemistry and Immunofluorescence in human samples. All other applications and species not yet tested.
Figure 4 Western Blot Validation in Mouse P815 Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: LSD1 3761, (A: 1 &956,g/mL, B: 2 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 6 Immunofluorescence Validation of LSD1 in human breast carcinoma TissueImmunofluorescent analysis of 4% paraformaldehyde-fixed human breast carcinoma Tissue labeling LSD1 with 3761 at 20 &956,g/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green/blue).
Figure 5 Immunohistochemistry Validation of LSD1 in Human Breast Carcinoma Tissue Immunohistochemical analysis of paraffin-embedded human breast carcinoma Tissue using anti-LSD1 antibody (3761) at 2 &956,g/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT, antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4&730,C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.
Figure 1 Western Blot Validation in Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: LSD1 3761 (0.2 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 2 Independent Antibody Validation (IAV) via Protein Expression Profile in Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: LSD1 3761 (0.2 &956,g/mL), LSD1 14-050 (1 &956,g/mL), beta-actin 3779 (1 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.
Figure 3 Western Blot Validation in Mouse TissuesLoading: 15 &956,g of lysates per lane.Antibodies: LSD1 3761 (0.2 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.